You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 2, February 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Glucagon on Hepatic Blood Flow

An Experimental Study in the Dog

Nils G. Kock, MD; Bernard Roding, MD; Paul Hahnloser, MD; Sten Tibblin, MD; Worthington G. Schenk, Jr, MD

AMA Arch Surg. 1970;100(2):147-149.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Glucagon, the polypeptide humoral substance produced mainly by the alpha cells of the pancreas, is generally considered as a metabolic hormone. Its influence on carbohydrate metabolism has been widely studied and is fairly well known.

In addition to the glycogenolytic action, glucagon has also been found to have an inhibitory effect on gastrointestinal motility1-3 and gastric acid secretion.4,5 By which mechanisms these actions are produced by glucagon and if they are of any physiological significance is not known.

The effect of glucagon on the cardiovascular system has been subject to much less study. In 1959, Shoemaker et al,6 using sulfobromophthalein (Bromsulphalein [BSP]) methods, studied the effect of glucagon on hepatic blood flow in dogs. They found an increase of blood flow which coincided with the serum glucose increase. In 1962, Merrill et al7 reported the effect of glucagon on the superior mesenteric vascular bed. In their . . . [Full Text PDF of this Article]


Author Affiliations

Buffalo

From the Department of Surgery, State University of New York at Buffalo, and the Surgical Research Laboratories of the Edward J. Meyer Memorial Hospital, Buffalo. Dr. Kock is now at the University of Göteborg, Göteborg, Sweden; Dr. Roding, the University of Amsterdam, Amsterdam; Dr. Hahnloser, the University Surgical Clinic, Zurich, Switzerland; and Dr. Tibblin, the University of Lund, Lund, Sweden. Drs. Kock, Roding, Hahnloser, and Tibblin participated in this study as Buswell fellows in surgical research.


Footnotes

Submitted for publication April 14, 1969.

Reprint requests to Department of Surgery, Edward J. Meyer Memorial Hospital, 462 Grider St, Buffalo 14215 (Dr. Schenk).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.